SparingVision to Present at the 40th Annual J.P. Morgan Healthcare Conference
Paris, January 6 2022 – SparingVision, a genomic medicine company developing vision saving treatments for ocular diseases, today announces that it will present at the virtual 40th Annual J.P. Morgan Healthcare Conference on January 11th, 2022. Stéphane Boissel, President and CEO, will make a formal presentation which will be followed by a Q&A at 8:30am ET / 13:30 GMT/ 14:30 CET.